Damien Zanker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Damien Zanker has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
Weisan Chen
T cell Laboratory; School of Molecular Science; La Trobe University; Bundoora, Victoria, Australia
9 shared publicationsNikola Baschuk
6 shared publications- Weisan Chen
Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia
6 shared publications - Belinda S. Parker
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
5 shared publications - Jason Waithman
School of Biomedical Sciences, The University of Western Australia, Perth, Australia
5 shared publications - Katie L. Owen
Peter MacCallum Cancer Centre 1 Cancer Evolution and Metastasis Program Melbourne, Australia
5 shared publications
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S1 from Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
- Open Access
- 24 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-16
Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis
The concept that extracellular vesicles (EVs) from the diet can be absorbed by the intestinal tract of the consuming organism, be bioavailable in various organs, and in-turn exert phenotypic changes is highly debatable. Here, we isolate EVs from both raw and commercial bovine milk and characterize them by electron microscopy, nanoparticle tracking analysis, western blotting, quantitative proteomics and small RNA sequencing analysis. Orally administered bovine milk-derived EVs survive the harsh degrading conditions of the gut, in mice, and is subsequently detected in multiple organs. Milk-derived EVs orally administered to mice implanted with colorectal and breast cancer cells reduce the primary tumor burden. Intriguingly, despite the reduction in primary tumor growth, milk-derived EVs accelerate metastasis in breast and pancreatic cancer mouse models. Proteomic and biochemical analysis reveal the induction of senescence and epithelial-to-mesenchymal transition in cancer cells upon treatment with milk-derived EVs. Timing of EV administration is critical as oral administration after resection of the primary tumor reverses the pro-metastatic effects of milk-derived EVs in breast cancer models. Taken together, our study provides context-based and opposing roles of milk-derived EVs as metastasis inducers and suppressors.
- 24 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-16
Open AccessOral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis
The concept that extracellular vesicles (EVs) from the diet can be absorbed by the intestinal tract of the consuming organism, be bioavailable in various organs, and in-turn exert phenotypic changes is highly debatable. Here, we isolate EVs from both raw and commercial bovine milk and characterize them by electron microscopy, nanoparticle tracking analysis, western blotting, quantitative proteomics and small RNA sequencing analysis. Orally administered bovine milk-derived EVs survive the harsh degrading conditions of the gut, in mice, and is subsequently detected in multiple organs. Milk-derived EVs orally administered to mice implanted with colorectal and breast cancer cells reduce the primary tumor burden. Intriguingly, despite the reduction in primary tumor growth, milk-derived EVs accelerate metastasis in breast and pancreatic cancer mouse models. Proteomic and biochemical analysis reveal the induction of senescence and epithelial-to-mesenchymal transition in cancer cells upon treatment with milk-derived EVs. Timing of EV administration is critical as oral administration after resection of the primary tumor reverses the pro-metastatic effects of milk-derived EVs in breast cancer models. Taken together, our study provides context-based and opposing roles of milk-derived EVs as metastasis inducers and suppressors.
- 15 January 2021
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 70 (8) , 2125-2138
Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer
Competent type I IFN signaling is the lynchpin of most immune surveillance mechanisms and has recently proven critical to the efficacy of several anticancer agents. Expression of the type I IFN receptor, IFNAR, underpins type I IFN responsiveness in all cells and facilitates the activation and cytotoxic potential of lymphocytes, while loss of IFNAR on lymphocytes has previously been associated with tumor progression and poor patient survival. This study underscores the importance of intact type I IFN signaling to NK cells in the regulation of tumorigenesis and metastasis, whereby ablation of NK cell IFNAR1 impairs antitumor activity and tumor clearance. Using a preclinical model of triple negative breast cancer, we identified that intact IFNAR on NK cells is required for an effective response to type I IFN-inducing immunotherapeutics that may be mediated by pathways associated with NK cell degranulation. Taken together, these data provide a rationale for considering the IFNAR status on NK cells when devising therapeutic strategies aimed at inducing systemic type I IFN signaling in breast cancer.
- 15 January 2021
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 70 (8) , 2125-2138
Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer
Competent type I IFN signaling is the lynchpin of most immune surveillance mechanisms and has recently proven critical to the efficacy of several anticancer agents. Expression of the type I IFN receptor, IFNAR, underpins type I IFN responsiveness in all cells and facilitates the activation and cytotoxic potential of lymphocytes, while loss of IFNAR on lymphocytes has previously been associated with tumor progression and poor patient survival. This study underscores the importance of intact type I IFN signaling to NK cells in the regulation of tumorigenesis and metastasis, whereby ablation of NK cell IFNAR1 impairs antitumor activity and tumor clearance. Using a preclinical model of triple negative breast cancer, we identified that intact IFNAR on NK cells is required for an effective response to type I IFN-inducing immunotherapeutics that may be mediated by pathways associated with NK cell degranulation. Taken together, these data provide a rationale for considering the IFNAR status on NK cells when devising therapeutic strategies aimed at inducing systemic type I IFN signaling in breast cancer.
- 15 May 2017
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 198 (10) , 3835-3845
Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands
CD8+ T cell immunosurveillance is based on recognizing oligopeptides presented by MHC class I molecules. Despite decades of study, the importance of protein ubiquitylation to peptide generation remains uncertain. In this study, we examined the ability of MLN7243, a recently described ubiquitin-activating enzyme E1 inhibitor, to block overall cytosolic peptide generation and generation of specific peptides from vaccinia- and influenza A virus–encoded proteins. We show that MLN7243 rapidly inhibits ubiquitylation in a variety of cell lines and can profoundly reduce the generation of cytosolic peptides. Kinetic analysis of specific peptide generation reveals that ubiquitylation of defective ribosomal products is rate limiting in generating class I peptide complexes. More generally, our findings demonstrate that the requirement for ubiquitylation in MHC class I–restricted Ag processing varies with class I allomorph, cell type, source protein, and peptide context. Thus, ubiquitin-dependent and -independent pathways robustly contribute to MHC class I–based immunosurveillance.
- 15 May 2017
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 198 (10) , 3835-3845
Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands
CD8+ T cell immunosurveillance is based on recognizing oligopeptides presented by MHC class I molecules. Despite decades of study, the importance of protein ubiquitylation to peptide generation remains uncertain. In this study, we examined the ability of MLN7243, a recently described ubiquitin-activating enzyme E1 inhibitor, to block overall cytosolic peptide generation and generation of specific peptides from vaccinia- and influenza A virus–encoded proteins. We show that MLN7243 rapidly inhibits ubiquitylation in a variety of cell lines and can profoundly reduce the generation of cytosolic peptides. Kinetic analysis of specific peptide generation reveals that ubiquitylation of defective ribosomal products is rate limiting in generating class I peptide complexes. More generally, our findings demonstrate that the requirement for ubiquitylation in MHC class I–restricted Ag processing varies with class I allomorph, cell type, source protein, and peptide context. Thus, ubiquitin-dependent and -independent pathways robustly contribute to MHC class I–based immunosurveillance.
- Open Access
- 2 April 2015
- Published by Taylor & Francis in OncoImmunology
- Vol. 4 (8) , e1019198
Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103−and XCR1+CD103+dendritic cells
The question of which dendritic cells (DCs) cross-present peripheral tumor antigens remains unanswered. We assessed the ability of multiple skin-derived and lymphoid resident DCs to perform this function in a novel orthotopic murine melanoma model where tumor establishment and expansion is within the skin. Two migratory populations defined as CD103−XCR1+ and CD103+XCR1+ efficiently cross-presented melanoma-derived antigen, with the CD103−XCR1+ DCs surprisingly dominating this process. These results are critical for understanding how antitumor CD8+ T cell immunity is coordinated to tumor antigens present within the skin.
- 2 April 2015
- Published by Taylor & Francis in OncoImmunology
- Vol. 4 (8) , e1019198
Open AccessCross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103−and XCR1+CD103+dendritic cells
The question of which dendritic cells (DCs) cross-present peripheral tumor antigens remains unanswered. We assessed the ability of multiple skin-derived and lymphoid resident DCs to perform this function in a novel orthotopic murine melanoma model where tumor establishment and expansion is within the skin. Two migratory populations defined as CD103−XCR1+ and CD103+XCR1+ efficiently cross-presented melanoma-derived antigen, with the CD103−XCR1+ DCs surprisingly dominating this process. These results are critical for understanding how antitumor CD8+ T cell immunity is coordinated to tumor antigens present within the skin.
- 23 January 2015
- Published by Wiley in Proteomics
- Vol. 15 (11) , 1808-1812
Compartment resolved reference proteome map from highly purified naïve, activated, effector, and memory CD8+ murine immune cells
Differentiation of CD8+ T lymphocytes into effector and memory cells is key for an adequate immune response and relies on complex interplay of pathways that convey signals from the cell surface to the nucleus. In this study, we investigated the proteome of four cytotoxic T‐cell subtypes; naïve, recently activated effector, effector, and memory cells. Cells were fractionated into membrane, cytosol, soluble nuclear, chromatin‐bound, and cytoskeletal compartments. Following LC‐MS/MS analysis, identified peptides were analyzed via MaxQuant. Compartment fractionation and gel‐LC‐MS separation resulted in 2399 proteins identified in total. Comparison between the different subsets resulted in 146 significantly regulated proteins for naïve and effector cells, followed by 116 for activated, and 55 for memory cells. Besides Granzyme B signaling (for activated and/ or effector cells vs. naïve cells), the most prominent changes occurred in the TCA cycle and aspartate degradation. These changes suggest that correct balancing of metabolism is key for differentiation processes. All MS data have been deposited in the ProteomeXchange with identifier PXD001065 (http://proteomecentral.proteomexchange.org/dataset/PXD001065).
- 23 January 2015
- Published by Wiley in Proteomics
- Vol. 15 (11) , 1808-1812
Compartment resolved reference proteome map from highly purified naïve, activated, effector, and memory CD8+ murine immune cells
Differentiation of CD8+ T lymphocytes into effector and memory cells is key for an adequate immune response and relies on complex interplay of pathways that convey signals from the cell surface to the nucleus. In this study, we investigated the proteome of four cytotoxic T‐cell subtypes; naïve, recently activated effector, effector, and memory cells. Cells were fractionated into membrane, cytosol, soluble nuclear, chromatin‐bound, and cytoskeletal compartments. Following LC‐MS/MS analysis, identified peptides were analyzed via MaxQuant. Compartment fractionation and gel‐LC‐MS separation resulted in 2399 proteins identified in total. Comparison between the different subsets resulted in 146 significantly regulated proteins for naïve and effector cells, followed by 116 for activated, and 55 for memory cells. Besides Granzyme B signaling (for activated and/ or effector cells vs. naïve cells), the most prominent changes occurred in the TCA cycle and aspartate degradation. These changes suggest that correct balancing of metabolism is key for differentiation processes. All MS data have been deposited in the ProteomeXchange with identifier PXD001065 (http://proteomecentral.proteomexchange.org/dataset/PXD001065).
- 6 January 2015
- Published by Wiley in Immunology & Cell Biology
- Vol. 93 (5) , 500-507
T cells recognizing a 11mer influenza peptide complexed to H‐2Db show promiscuity for peptide length
T‐cell repertoire is selected according to self peptide–MHC (major histocompatibility complex) complexes in the thymus. Although most peripheral T cells recognize specific pathogen‐derived peptides complexed to self‐MHC exclusively, some possess cross‐reactivity to other self or foreign peptides presented by self‐MHC molecules; a phenomenon often termed T‐cell receptor (TCR) promiscuity or degeneracy. TCR promiscuity has been attributed to various autoimmune conditions. On the other hand, it is considered a mechanism for a relatively limited TCR repertoire to deal with a potentially much larger antigenic peptide repertoire. Such property has also been utilized to bypass self‐tolerance for cancer vaccine development. Although many studies explored such degeneracy for peptide of the same length, few studies reported such properties for peptides of different length. In this study, we finely characterized the CD8+ T‐cell response specific for a 11mer peptide derived from influenza A viral polymerase basic protein 2. The short‐term T‐cell line, despite possessing highly biased TCR, was able to react with multiple peptides of different length sharing the same core sequence. Out data clearly showed the importance of detailed and quantitative assessments for such T‐cell specificity. Our data also emphasize the importance of biochemical demonstration of the naturally presented minimal peptide.
- 6 January 2015
- Published by Wiley in Immunology & Cell Biology
- Vol. 93 (5) , 500-507
T cells recognizing a 11mer influenza peptide complexed to H‐2Db show promiscuity for peptide length
T‐cell repertoire is selected according to self peptide–MHC (major histocompatibility complex) complexes in the thymus. Although most peripheral T cells recognize specific pathogen‐derived peptides complexed to self‐MHC exclusively, some possess cross‐reactivity to other self or foreign peptides presented by self‐MHC molecules; a phenomenon often termed T‐cell receptor (TCR) promiscuity or degeneracy. TCR promiscuity has been attributed to various autoimmune conditions. On the other hand, it is considered a mechanism for a relatively limited TCR repertoire to deal with a potentially much larger antigenic peptide repertoire. Such property has also been utilized to bypass self‐tolerance for cancer vaccine development. Although many studies explored such degeneracy for peptide of the same length, few studies reported such properties for peptides of different length. In this study, we finely characterized the CD8+ T‐cell response specific for a 11mer peptide derived from influenza A viral polymerase basic protein 2. The short‐term T‐cell line, despite possessing highly biased TCR, was able to react with multiple peptides of different length sharing the same core sequence. Out data clearly showed the importance of detailed and quantitative assessments for such T‐cell specificity. Our data also emphasize the importance of biochemical demonstration of the naturally presented minimal peptide.